CN104082752A - 一种含有角鲨烯的海狗油软胶囊 - Google Patents
一种含有角鲨烯的海狗油软胶囊 Download PDFInfo
- Publication number
- CN104082752A CN104082752A CN201410297588.1A CN201410297588A CN104082752A CN 104082752 A CN104082752 A CN 104082752A CN 201410297588 A CN201410297588 A CN 201410297588A CN 104082752 A CN104082752 A CN 104082752A
- Authority
- CN
- China
- Prior art keywords
- squalene
- seal oil
- dha
- dpa
- epa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 title claims abstract description 19
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 title claims abstract description 19
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 229940031439 squalene Drugs 0.000 title claims abstract description 19
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 title claims abstract description 19
- 239000007901 soft capsule Substances 0.000 title claims abstract description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 7
- 239000002775 capsule Substances 0.000 claims abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 7
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 7
- 229940046009 vitamin E Drugs 0.000 claims abstract description 7
- 239000011709 vitamin E Substances 0.000 claims abstract description 7
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 claims description 2
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 claims description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 2
- 235000021290 n-3 DPA Nutrition 0.000 claims description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 abstract description 9
- 210000004369 blood Anatomy 0.000 abstract description 9
- 239000008280 blood Substances 0.000 abstract description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 7
- 230000006870 function Effects 0.000 abstract description 7
- 235000021294 Docosapentaenoic acid Nutrition 0.000 abstract description 4
- 108010010803 Gelatin Proteins 0.000 abstract description 4
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 4
- 229920000159 gelatin Polymers 0.000 abstract description 4
- 239000008273 gelatin Substances 0.000 abstract description 4
- 235000019322 gelatine Nutrition 0.000 abstract description 4
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 208000007536 Thrombosis Diseases 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 208000029078 coronary artery disease Diseases 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 3
- 210000000056 organ Anatomy 0.000 abstract description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 abstract description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 235000019197 fats Nutrition 0.000 abstract description 2
- 235000020660 omega-3 fatty acid Nutrition 0.000 abstract description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 abstract description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 3
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 3
- 230000036772 blood pressure Effects 0.000 abstract 1
- 150000002430 hydrocarbons Chemical class 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 230000019240 optic nerve development Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000004382 potting Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- -1 that Chemical compound 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/10—Fish meal or powder; Granules, agglomerates or flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明提供了一种含有角鲨烯的海狗油软胶囊，主要原料是海狗油[含EPA（二十碳五烯酸）、DHA（二十二碳六烯酸）、DPA（二十二碳五烯酸）]、角鲨烯（含三十碳六烯）、维生素E，辅料为水、甘油和食用动物明胶。本发明的有益效果是：该海狗油软胶囊将ω-3高度不饱和脂肪酸（EPA、DHA、DPA）和高度不饱和烃类化合物（角鲨烯）有效结合在一起，成分之间进一步协同作用，具有更好的降血脂、溶解血栓、降血压及预防冠心病等心脑血管疾病的作用，并能净化血液、恢复受损器官功能。
Description
（一）技术领域
本发明涉及一种海狗油软胶囊，尤其是一种含有角鲨烯的海狗油软胶囊，属于保健食品技术领域。
（二）背景技术
目前，随着生活水平的不断提高，人们对高脂肪肉类食品的摄入量不断增加，伴随而来的是血液中脂肪含量的不断升高，并且由此引起的动脉血管硬化、血栓、冠心病等疾病,日益影响和危害了中老年人的健康和生活质量。为了预防此类疾病的发生，人们开始食用一些海狗油类产品，由于市场上现有的各种海狗油类产品普遍存在：有效成分简单、功效成分含量低、功效成分配比不合理，造成产品功能单一、效果不明显的缺点，很难起到理想的预防疾病的作用。
（三）发明内容
本发明为了弥补现有技术的不足，提供了一种含有角鲨烯的海狗油软胶囊，主要有效成分是：海狗油[含有EPA（二十碳五烯酸）、DHA（二十二碳六烯酸）、DPA（二十二碳五烯酸）]、角鲨烯（三十碳六烯）、维生素E，主要辅料为水、甘油和食用动物明胶。
海狗油中的EPA：俗称“血管清道夫”，具有防止血管硬化、心脑血管栓塞，降低高血压、高血脂及胆固醇，抑制血小板凝聚等作用。DHA：俗称“脑黄金”，是脑组织和视神经发育及功能发挥所必须的营养物质。可用于增强记忆力，促进婴幼儿智力开发及提高智商，预防和治疗老年痴呆症。DPA：可促进和提高人体的免疫力。对糖尿病、类风湿性关节炎、牛皮癣、气喘病，溃疡性大小肠炎等均有治疗作用。
角鲨烯具有类似红细胞那样摄取氧的功能，生成活化的氧化鲨烯，随血液被运输到机体末端细胞中释放出氧,因此可以明显改善机体细胞的缺氧状态，活化身体机能细胞,增强由于心脑血管疾病引起衰退的身体各器官的功能。角鲨烯还有净化血液的功效，血液净化之后，很多因为血液循环不良所导致的病变，比如心脏病、高血压、低血压及中风等，都可以得到预防或治疗。
本发明的有益效果是：该海狗油软胶囊将ω-3高度不饱和脂肪酸（EPA、DHA、DPA）和高度不饱和烃类化合物（角鲨烯）有效结合在一起，成分之间进一步协同作用，具有更好的降血脂、溶解血栓、降血压及预防冠心病等心脑血管疾病的作用，同时能够净化血液、尽快恢复各受损器官的功能。
维生素E能够保护高度不饱和脂肪酸（EPA、DHA、DPA）和角鲨烯不被氧化，延长产品保质期。
（四）具体实施方式
1、配制内容物：将原材料海狗油、角鲨烯、维生素E按照一定的配方混合到一起，搅拌均匀，胶囊内容物功效成分的质量百分比为EPA：8～12%、DHA：12～16%、DPA：7~10%、角鲨烯30~35%，其余成分为1%的维生素E和海狗油中的其它非功效成分。
2、制作胶囊体材料：以食用明胶、甘油和纯净水为囊体原料，将甘油和纯净水按照比例注入溶胶罐内，加热搅拌至75℃左右，再加入明胶，继续搅拌20～30分钟后真空脱泡，制作得到囊体材料。
3、将配好的内容物和胶囊体经过压丸、成型、洗丸、干燥，制成成品海狗油软胶囊。
Claims (2)
1.一种含有角鲨烯的海狗油软胶囊，其特征在于：胶囊内容物原料的质量百分比为海狗油[含有EPA（二十碳五烯酸）、DHA（二十二碳六烯酸）、DPA（二十二碳五烯酸）]：65～70% 、角鲨烯：30～35% 、维生素E：1% 。
2. 根据权利要求1所述的一种含有角鲨烯的海狗油软胶囊，其特征在于：胶囊内容物功效成分的质量百分比为EPA：8～12%、DHA：12～16%、DPA：7~10%、角鲨烯30~35%，其余成分为1%的维生素E和海狗油中的其它非功效成分。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410297588.1A CN104082752A (zh) | 2014-06-29 | 2014-06-29 | 一种含有角鲨烯的海狗油软胶囊 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410297588.1A CN104082752A (zh) | 2014-06-29 | 2014-06-29 | 一种含有角鲨烯的海狗油软胶囊 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104082752A true CN104082752A (zh) | 2014-10-08 |
Family
ID=51630600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410297588.1A Pending CN104082752A (zh) | 2014-06-29 | 2014-06-29 | 一种含有角鲨烯的海狗油软胶囊 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104082752A (zh) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1437955A (zh) * | 2003-03-24 | 2003-08-27 | 刘威 | 精制海狗油在制备防治更年期综合症和痛经药中的应用 |
| CN1518989A (zh) * | 2003-01-21 | 2004-08-11 | 刘 威 | 海狗油软胶囊及其在制备调节血脂保健品中的应用 |
| US20110268811A1 (en) * | 2010-04-30 | 2011-11-03 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans |
| CN102551041A (zh) * | 2010-12-08 | 2012-07-11 | 浙江金诺康生物制药有限公司 | 一种精制海狗油、软胶囊及其在改善化学性肝损伤保健品中的应用 |
| CN103800435A (zh) * | 2014-02-12 | 2014-05-21 | 山东天地健生物工程有限公司 | 一种海狗油软胶囊 |
-
2014
- 2014-06-29 CN CN201410297588.1A patent/CN104082752A/zh active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1518989A (zh) * | 2003-01-21 | 2004-08-11 | 刘 威 | 海狗油软胶囊及其在制备调节血脂保健品中的应用 |
| CN1437955A (zh) * | 2003-03-24 | 2003-08-27 | 刘威 | 精制海狗油在制备防治更年期综合症和痛经药中的应用 |
| US20110268811A1 (en) * | 2010-04-30 | 2011-11-03 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Composition and method to improve blood lipid profiles and optionally reduce low density lipoprotein (ldl) per-oxidation in humans |
| CN102551041A (zh) * | 2010-12-08 | 2012-07-11 | 浙江金诺康生物制药有限公司 | 一种精制海狗油、软胶囊及其在改善化学性肝损伤保健品中的应用 |
| CN103800435A (zh) * | 2014-02-12 | 2014-05-21 | 山东天地健生物工程有限公司 | 一种海狗油软胶囊 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104082751A (zh) | 一种含有虾青素的深海鱼油软胶囊 | |
| CN102942987B (zh) | 一种利用复合蛋白酶从鲐鱼鱼头和内脏中提取鱼油的方法 | |
| CN104000208A (zh) | 一种含有角鲨烯的深海鱼油软胶囊 | |
| CN104055123A (zh) | 一种含有γ-亚麻酸的深海鱼油软胶囊 | |
| CN103989179A (zh) | 含有银杏叶提取物的深海鱼油软胶囊 | |
| CN101961352A (zh) | 一种无腥味的自乳化的鱼油软胶囊 | |
| CN103989181A (zh) | 核桃油鱼油软胶囊 | |
| CN102232430A (zh) | 保健油 | |
| CN103989184A (zh) | 一种含有花生四烯酸的藻油软胶囊 | |
| CN104127857A (zh) | 一种鱼油软胶囊及其制备方法 | |
| CN107173807A (zh) | 一种含藻类提取物的抗氧化保健营养组合物 | |
| CN101194913A (zh) | 治疗血脂偏高的天然海豹油浓缩生物制剂及其制备工艺 | |
| CN103989180B (zh) | 含有丹参提取物的深海鱼油软胶囊 | |
| CN103989176B (zh) | 含有葛根提取物的深海鱼油软胶囊 | |
| CN104082752A (zh) | 一种含有角鲨烯的海狗油软胶囊 | |
| CN103652924A (zh) | 一种复方葡萄籽油软胶囊及其制备方法 | |
| CN104666370A (zh) | 一种深海鱼油软胶囊及其制备方法 | |
| CN104082741A (zh) | 一种含有虾青素的海狗油软胶囊 | |
| CN103535729A (zh) | 西洋参提取物、大鲵提取物的混合保健食品 | |
| CN104055117A (zh) | 一种含有花生四烯酸的海狗油软胶囊 | |
| CN103989175A (zh) | 含有罗布麻提取物的深海鱼油软胶囊 | |
| CN103989185A (zh) | 一种含有辅酶q10的深海鱼油软胶囊 | |
| CN104187727A (zh) | 含有丹参提取物的海狗油软胶囊 | |
| CN104172151A (zh) | 一种含有辅酶q10的海狗油软胶囊 | |
| CN104187676A (zh) | 含有葛根提取物的海狗油软胶囊 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141008 |